Fernando Graça Aranha
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Fernando Graça Aranha has a total of 223 co-authors. Here are the top co-authors by number of shared publications:
- Milena Soriano Marcolino
Medical School, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil
15 shared publications - Daniela Ponce
Sao Paulo State University (UNESP) - Botucatu Medicine School, Botucatu, Brazil
13 shared publications - Matheus Carvalho Alves Nogueira
Instituto do Coração do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, Brasil
13 shared publications - Fernando Anschau
Grupo Hospitalar Conceição Porto Alegre Brazil
12 shared publications - Heloisa Reniers Vianna
Hospital Universitário Ciências Médicas, Belo Horizonte, Brazil
12 shared publications - Karen Brasil Ruschel
Institute for Health Technology Assessment (IATS/ CNPq), Porto Alegre, Brazil
12 shared publications
Latest Publications
- Open Access
- 1 January 2026
- Published by FapUNIFESP (SciELO) in Revista do Colégio Brasileiro de Cirurgiões
- Vol. 53
Doença arterial periférica como fator de risco para fibrilação atrial no período pós-operatório de cirurgia de revascularização do miocárdio: um estudo de coorte retrospectivo
RESUMO Introdução: A fibrilação atrial pós-operatória (FAPO) é a complicação mais comum da cirurgia de revascularização miocárdica, sendo associada a fatores predisponentes e a desfechos como aumento do tempo de internação hospitalar, maiores taxas de acidente vascular encefálico e mortalidade. O objetivo deste estudo é estimar a incidência de FAPO e os fatores e desfechos associados, com ênfase na doença arterial periférica. Métodos: Foi realizado um estudo de coorte retrospectivo, envolvendo pacientes adultos admitidos na unidade de terapia intensiva no período pós-operatório imediato de cirurgia de revascularização miocárdica em um hospital privado da região sul do Brasil. Foram coletados dados sociodemográficos, comorbidades, tempo de internação hospitalar e em unidade de terapia intensiva, ocorrência de acidente vascular encefálico e óbito. Análises multivariadas foram realizadas para identificar relações independentes entre as variáveis, utilizando regressão de Poisson com estimador robusto. Os riscos relativos e os intervalos de confiança de 95% foram estimados. Resultados: 421 pacientes foram incluídos. A incidência de FAPO foi de 23,8% (100 pacientes), associada de forma estatisticamente significativa e independente à maior idade do paciente (p<0,001), à hipertensão arterial sistêmica (p<0,001) e à doença arterial periférica (p<0,001). O aumento da incidência de FAPO também foi associado ao maior tempo de internação hospitalar e em unidade de terapia intensiva. Conclusão: A maior incidência de FAPO após revascularização miocárdica foi associada à doença arterial periférica, maior idade e hipertensão arterial sistêmica.
- 1 January 2026
- Published by FapUNIFESP (SciELO) in Revista do Colégio Brasileiro de Cirurgiões
- Vol. 53
Open AccessDoença arterial periférica como fator de risco para fibrilação atrial no período pós-operatório de cirurgia de revascularização do miocárdio: um estudo de coorte retrospectivo
RESUMO Introdução: A fibrilação atrial pós-operatória (FAPO) é a complicação mais comum da cirurgia de revascularização miocárdica, sendo associada a fatores predisponentes e a desfechos como aumento do tempo de internação hospitalar, maiores taxas de acidente vascular encefálico e mortalidade. O objetivo deste estudo é estimar a incidência de FAPO e os fatores e desfechos associados, com ênfase na doença arterial periférica. Métodos: Foi realizado um estudo de coorte retrospectivo, envolvendo pacientes adultos admitidos na unidade de terapia intensiva no período pós-operatório imediato de cirurgia de revascularização miocárdica em um hospital privado da região sul do Brasil. Foram coletados dados sociodemográficos, comorbidades, tempo de internação hospitalar e em unidade de terapia intensiva, ocorrência de acidente vascular encefálico e óbito. Análises multivariadas foram realizadas para identificar relações independentes entre as variáveis, utilizando regressão de Poisson com estimador robusto. Os riscos relativos e os intervalos de confiança de 95% foram estimados. Resultados: 421 pacientes foram incluídos. A incidência de FAPO foi de 23,8% (100 pacientes), associada de forma estatisticamente significativa e independente à maior idade do paciente (p<0,001), à hipertensão arterial sistêmica (p<0,001) e à doença arterial periférica (p<0,001). O aumento da incidência de FAPO também foi associado ao maior tempo de internação hospitalar e em unidade de terapia intensiva. Conclusão: A maior incidência de FAPO após revascularização miocárdica foi associada à doença arterial periférica, maior idade e hipertensão arterial sistêmica.
- Open Access
- 1 January 2026
- Published by FapUNIFESP (SciELO) in Revista do Colégio Brasileiro de Cirurgiões
- Vol. 53
Peripheral arterial disease as a risk factor for atrial fibrillation in the postoperative period of myocardial revascularization: a retrospective cohort study
Introduction: Postoperative atrial fibrillation (POAF) is the most common complication of myocardial revascularization surgery, associated with predisposing factors and outcomes such as increased hospital stay, higher stroke and mortality rates. The objective of this study is to estimate the incidence of POAF and associated factors and outcomes, with emphasis on peripheral arterial disease. Methods: A retrospective cohort study was carried out involving adult patients admitted to admitted to the intensive care unit in the immediate postoperative period of myocardial revascularization surgery in a private hospital in South Brazil. Sociodemographic data, comorbidities, hospital and intensive care unit stay, occurrence of stroke and death were collected. Multivariate analyses were performed to identify independent relationships between variables using Poisson Regression with a robust estimator. Relative risks and 95% confidence intervals were estimated. Results: A total of 421 patients were included. The incidence of POAF was 23.8% (100 patients), statistically and independently associated with patient’s older age (p<0.001), with systemic arterial hypertension (p<0.001) and with peripheral arterial disease (p<0.001). Increased incidence of POAF was also associated with increased hospital and intensive care unit length of stay. Conclusion: A higher incidence of POAF after myocardial revascularization was associated with peripheral arterial disease, older age, and systemic arterial hypertension.
- 1 January 2026
- Published by FapUNIFESP (SciELO) in Revista do Colégio Brasileiro de Cirurgiões
- Vol. 53
Open AccessPeripheral arterial disease as a risk factor for atrial fibrillation in the postoperative period of myocardial revascularization: a retrospective cohort study
Introduction: Postoperative atrial fibrillation (POAF) is the most common complication of myocardial revascularization surgery, associated with predisposing factors and outcomes such as increased hospital stay, higher stroke and mortality rates. The objective of this study is to estimate the incidence of POAF and associated factors and outcomes, with emphasis on peripheral arterial disease. Methods: A retrospective cohort study was carried out involving adult patients admitted to admitted to the intensive care unit in the immediate postoperative period of myocardial revascularization surgery in a private hospital in South Brazil. Sociodemographic data, comorbidities, hospital and intensive care unit stay, occurrence of stroke and death were collected. Multivariate analyses were performed to identify independent relationships between variables using Poisson Regression with a robust estimator. Relative risks and 95% confidence intervals were estimated. Results: A total of 421 patients were included. The incidence of POAF was 23.8% (100 patients), statistically and independently associated with patient’s older age (p<0.001), with systemic arterial hypertension (p<0.001) and with peripheral arterial disease (p<0.001). Increased incidence of POAF was also associated with increased hospital and intensive care unit length of stay. Conclusion: A higher incidence of POAF after myocardial revascularization was associated with peripheral arterial disease, older age, and systemic arterial hypertension.
- Open Access
- 15 January 2025
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 25 (1) , 1-10
Clinical outcomes of COVID-19 in patients with liver cirrhosis - a propensity-matched analysis from a multicentric Brazilian cohort
Cirrhosis has been pointed out as a clinical entity that leads to worse clinical prognosis in COVID-19 patients. However, this concept is controversial in the literature. We aimed to evaluate clinical outcomes by comparing patients with cirrhosis to those without cirrhosis in a Brazilian cohort. Data from 20,164 COVID-19 inpatients were collected from 41 hospitals in Brazil between March to September 2020 and March 2021 to August 2022. We compared 117 patients with cirrhosis to 632 matched controls. A propensity score model was used to adjust for potential confounding variables, incorporating some predictors: age, sex at birth, number of comorbidities, hospital of admission, whether it was an in-hospital clinical manifestation of COVID-19, and admission year. Closeness was defined as being within 0.16 standard deviations of the logit of the propensity score. The median age was 61 (IQR 50–70) years old, and 63.4% were men. There were no significant differences in the self-reported symptoms. Patients with cirrhosis had lower median hemoglobin levels (10.8 vs. 13.1 g/dl), lower platelets (127,000 vs. 200,000 cells/mm3), and leukocyte counts, as well as lower median C-reactive protein (63.0 vs. 76.0 p = 0.044) when compared to controls. They also had higher mortality compared to matched controls (51.3% vs. 21.7%, p < 0.001). They also had higher frequencies of admission in an intensive care unit (51.3% vs. 38.0%, p = 0.007), invasive mechanical ventilation (43.9% vs. 26.6%, p < 0.001), dialysis (17.9% vs. 11.1%, p = 0.038), septic shock (23.9% vs. 14.9%; p = 0.015) and institution of palliative care (19.7% vs. 7.4%; p < 0.001). This study has shown that COVID-19 inpatients with cirrhosis had significantly higher incidence of severe outcomes, as well as higher frequency of institution of palliative care when compared to matched controls. Our findings underscore the need for these patients to receive particular attention from healthcare teams and allocated resources.
- 15 January 2025
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 25 (1) , 1-10
Open AccessClinical outcomes of COVID-19 in patients with liver cirrhosis - a propensity-matched analysis from a multicentric Brazilian cohort
Cirrhosis has been pointed out as a clinical entity that leads to worse clinical prognosis in COVID-19 patients. However, this concept is controversial in the literature. We aimed to evaluate clinical outcomes by comparing patients with cirrhosis to those without cirrhosis in a Brazilian cohort. Data from 20,164 COVID-19 inpatients were collected from 41 hospitals in Brazil between March to September 2020 and March 2021 to August 2022. We compared 117 patients with cirrhosis to 632 matched controls. A propensity score model was used to adjust for potential confounding variables, incorporating some predictors: age, sex at birth, number of comorbidities, hospital of admission, whether it was an in-hospital clinical manifestation of COVID-19, and admission year. Closeness was defined as being within 0.16 standard deviations of the logit of the propensity score. The median age was 61 (IQR 50–70) years old, and 63.4% were men. There were no significant differences in the self-reported symptoms. Patients with cirrhosis had lower median hemoglobin levels (10.8 vs. 13.1 g/dl), lower platelets (127,000 vs. 200,000 cells/mm3), and leukocyte counts, as well as lower median C-reactive protein (63.0 vs. 76.0 p = 0.044) when compared to controls. They also had higher mortality compared to matched controls (51.3% vs. 21.7%, p < 0.001). They also had higher frequencies of admission in an intensive care unit (51.3% vs. 38.0%, p = 0.007), invasive mechanical ventilation (43.9% vs. 26.6%, p < 0.001), dialysis (17.9% vs. 11.1%, p = 0.038), septic shock (23.9% vs. 14.9%; p = 0.015) and institution of palliative care (19.7% vs. 7.4%; p < 0.001). This study has shown that COVID-19 inpatients with cirrhosis had significantly higher incidence of severe outcomes, as well as higher frequency of institution of palliative care when compared to matched controls. Our findings underscore the need for these patients to receive particular attention from healthcare teams and allocated resources.
- Open Access
- 4 October 2023
- Published by Springer Nature in BMC Nephrology
- Vol. 24 (1) , 1-12
Temporal validation of the MMCD score to predict kidney replacement therapy and in-hospital mortality in COVID-19 patients
Background: Acute kidney injury has been described as a common complication in patients hospitalized with COVID-19, which may lead to the need for kidney replacement therapy (KRT) in its most severe forms. Our group developed and validated the MMCD score in Brazilian COVID-19 patients to predict KRT, which showed excellent performance using data from 2020. This study aimed to validate the MMCD score in a large cohort of patients hospitalized with COVID-19 in a different pandemic phase and assess its performance to predict in-hospital mortality. Methods: This study is part of the “Brazilian COVID-19 Registry”, a retrospective observational cohort of consecutive patients hospitalized for laboratory-confirmed COVID-19 in 25 Brazilian hospitals between March 2021 and August 2022. The primary outcome was KRT during hospitalization and the secondary was in-hospital mortality. We also searched literature for other prediction models for KRT, to assess the results in our database. Performance was assessed using area under the receiving operator characteristic curve (AUROC) and the Brier score. Results: A total of 9422 patients were included, 53.8% were men, with a median age of 59 (IQR 48–70) years old. The incidence of KRT was 8.8% and in-hospital mortality was 18.1%. The MMCD score had excellent discrimination and overall performance to predict KRT (AUROC: 0.916 [95% CI 0.909–0.924]; Brier score = 0.057). Despite the excellent discrimination and overall performance (AUROC: 0.922 [95% CI 0.914–0.929]; Brier score = 0.100), the calibration was not satisfactory concerning in-hospital mortality. A random forest model was applied in the database, with inferior performance to predict KRT requirement (AUROC: 0.71 [95% CI 0.69–0.73]). Conclusion: The MMCD score is not appropriate for in-hospital mortality but demonstrates an excellent predictive ability to predict KRT in COVID-19 patients. The instrument is low cost, objective, fast and accurate, and can contribute to supporting clinical decisions in the efficient allocation of assistance resources in patients with COVID-19.
- 4 October 2023
- Published by Springer Nature in BMC Nephrology
- Vol. 24 (1) , 1-12
Open AccessTemporal validation of the MMCD score to predict kidney replacement therapy and in-hospital mortality in COVID-19 patients
Background: Acute kidney injury has been described as a common complication in patients hospitalized with COVID-19, which may lead to the need for kidney replacement therapy (KRT) in its most severe forms. Our group developed and validated the MMCD score in Brazilian COVID-19 patients to predict KRT, which showed excellent performance using data from 2020. This study aimed to validate the MMCD score in a large cohort of patients hospitalized with COVID-19 in a different pandemic phase and assess its performance to predict in-hospital mortality. Methods: This study is part of the “Brazilian COVID-19 Registry”, a retrospective observational cohort of consecutive patients hospitalized for laboratory-confirmed COVID-19 in 25 Brazilian hospitals between March 2021 and August 2022. The primary outcome was KRT during hospitalization and the secondary was in-hospital mortality. We also searched literature for other prediction models for KRT, to assess the results in our database. Performance was assessed using area under the receiving operator characteristic curve (AUROC) and the Brier score. Results: A total of 9422 patients were included, 53.8% were men, with a median age of 59 (IQR 48–70) years old. The incidence of KRT was 8.8% and in-hospital mortality was 18.1%. The MMCD score had excellent discrimination and overall performance to predict KRT (AUROC: 0.916 [95% CI 0.909–0.924]; Brier score = 0.057). Despite the excellent discrimination and overall performance (AUROC: 0.922 [95% CI 0.914–0.929]; Brier score = 0.100), the calibration was not satisfactory concerning in-hospital mortality. A random forest model was applied in the database, with inferior performance to predict KRT requirement (AUROC: 0.71 [95% CI 0.69–0.73]). Conclusion: The MMCD score is not appropriate for in-hospital mortality but demonstrates an excellent predictive ability to predict KRT in COVID-19 patients. The instrument is low cost, objective, fast and accurate, and can contribute to supporting clinical decisions in the efficient allocation of assistance resources in patients with COVID-19.
- Open Access
- 6 June 2023
- Published by Springer Nature in BMC Medicine
- Vol. 21 (1) , 1-2
Correction: Development and validation of the MMCD score to predict kidney replacement therapy in COVID-19 patients
- 6 June 2023
- Published by Springer Nature in BMC Medicine
- Vol. 21 (1) , 1-2
Open AccessCorrection: Development and validation of the MMCD score to predict kidney replacement therapy in COVID-19 patients
- Open Access
- 1 March 2023
- Published by Springer Nature in Scientific Reports
- Vol. 13 (1) , 1-18
Potential and limitations of machine meta-learning (ensemble) methods for predicting COVID-19 mortality in a large inhospital Brazilian dataset
The majority of early prediction scores and methods to predict COVID-19 mortality are bound by methodological flaws and technological limitations (e.g., the use of a single prediction model). Our aim is to provide a thorough comparative study that tackles those methodological issues, considering multiple techniques to build mortality prediction models, including modern machine learning (neural) algorithms and traditional statistical techniques, as well as meta-learning (ensemble) approaches. This study used a dataset from a multicenter cohort of 10,897 adult Brazilian COVID-19 patients, admitted from March/2020 to November/2021, including patients [median age 60 (interquartile range 48–71), 46% women]. We also proposed new original population-based meta-features that have not been devised in the literature. Stacking has shown to achieve the best results reported in the literature for the death prediction task, improving over previous state-of-the-art by more than 46% in Recall for predicting death, with AUROC 0.826 and MacroF1 of 65.4%. The newly proposed meta-features were highly discriminative of death, but fell short in producing large improvements in final prediction performance, demonstrating that we are possibly on the limits of the prediction capabilities that can be achieved with the current set of ML techniques and (meta-)features. Finally, we investigated how the trained models perform on different hospitals, showing that there are indeed large differences in classifier performance between different hospitals, further making the case that errors are produced by factors that cannot be modeled with the current predictors.
- 1 March 2023
- Published by Springer Nature in Scientific Reports
- Vol. 13 (1) , 1-18
Open AccessPotential and limitations of machine meta-learning (ensemble) methods for predicting COVID-19 mortality in a large inhospital Brazilian dataset
The majority of early prediction scores and methods to predict COVID-19 mortality are bound by methodological flaws and technological limitations (e.g., the use of a single prediction model). Our aim is to provide a thorough comparative study that tackles those methodological issues, considering multiple techniques to build mortality prediction models, including modern machine learning (neural) algorithms and traditional statistical techniques, as well as meta-learning (ensemble) approaches. This study used a dataset from a multicenter cohort of 10,897 adult Brazilian COVID-19 patients, admitted from March/2020 to November/2021, including patients [median age 60 (interquartile range 48–71), 46% women]. We also proposed new original population-based meta-features that have not been devised in the literature. Stacking has shown to achieve the best results reported in the literature for the death prediction task, improving over previous state-of-the-art by more than 46% in Recall for predicting death, with AUROC 0.826 and MacroF1 of 65.4%. The newly proposed meta-features were highly discriminative of death, but fell short in producing large improvements in final prediction performance, demonstrating that we are possibly on the limits of the prediction capabilities that can be achieved with the current set of ML techniques and (meta-)features. Finally, we investigated how the trained models perform on different hospitals, showing that there are indeed large differences in classifier performance between different hospitals, further making the case that errors are produced by factors that cannot be modeled with the current predictors.
- Open Access
- 21 February 2023
- Published by Elsevier in International Journal of Infectious Diseases
- Vol. 130, 31-37
Clinical characteristics and outcomes of hospital-manifested COVID-19 among Brazilians
- 21 February 2023
- Published by Elsevier in International Journal of Infectious Diseases
- Vol. 130, 31-37
Open AccessClinical characteristics and outcomes of hospital-manifested COVID-19 among Brazilians
- 25 September 2022
- Published by Springer Nature in Internal and Emergency Medicine
- Vol. 17 (8) , 2299-2313
Hospital characteristics associated with COVID-19 mortality: data from the multicenter cohort Brazilian Registry
The COVID-19 pandemic caused unprecedented pressure over health care systems worldwide. Hospital-level data that may influence the prognosis in COVID-19 patients still needs to be better investigated. Therefore, this study analyzed regional socioeconomic, hospital, and intensive care units (ICU) characteristics associated with in-hospital mortality in COVID-19 patients admitted to Brazilian institutions. This multicenter retrospective cohort study is part of the Brazilian COVID-19 Registry. We enrolled patients ≥ 18 years old with laboratory-confirmed COVID-19 admitted to the participating hospitals from March to September 2020. Patients’ data were obtained through hospital records. Hospitals’ data were collected through forms filled in loco and through open national databases. Generalized linear mixed models with logit link function were used for pooling mortality and to assess the association between hospital characteristics and mortality estimates. We built two models, one tested general hospital characteristics while the other tested ICU characteristics. All analyses were adjusted for the proportion of high-risk patients at admission. Thirty-one hospitals were included. The mean number of beds was 320.4 ± 186.6. These hospitals had eligible 6556 COVID-19 admissions during the study period. Estimated in-hospital mortality ranged from 9.0 to 48.0%. The first model included all 31 hospitals and showed that a private source of funding (β = − 0.37; 95% CI − 0.71 to − 0.04; p = 0.029) and location in areas with a high gross domestic product (GDP) per capita (β = − 0.40; 95% CI − 0.72 to − 0.08; p = 0.014) were independently associated with a lower mortality. The second model included 23 hospitals and showed that hospitals with an ICU work shift composed of more than 50% of intensivists (β = − 0.59; 95% CI − 0.98 to − 0.20; p = 0.003) had lower mortality while hospitals with a higher proportion of less experienced medical professionals had higher mortality (β = 0.40; 95% CI 0.11–0.68; p = 0.006). The impact of those association increased according to the proportion of high-risk patients at admission. In-hospital mortality varied significantly among Brazilian hospitals. Private-funded hospitals and those located in municipalities with a high GDP had a lower mortality. When analyzing ICU-specific characteristics, hospitals with more experienced ICU teams had a reduced mortality.
- 25 September 2022
- Published by Springer Nature in Internal and Emergency Medicine
- Vol. 17 (8) , 2299-2313
Hospital characteristics associated with COVID-19 mortality: data from the multicenter cohort Brazilian Registry
The COVID-19 pandemic caused unprecedented pressure over health care systems worldwide. Hospital-level data that may influence the prognosis in COVID-19 patients still needs to be better investigated. Therefore, this study analyzed regional socioeconomic, hospital, and intensive care units (ICU) characteristics associated with in-hospital mortality in COVID-19 patients admitted to Brazilian institutions. This multicenter retrospective cohort study is part of the Brazilian COVID-19 Registry. We enrolled patients ≥ 18 years old with laboratory-confirmed COVID-19 admitted to the participating hospitals from March to September 2020. Patients’ data were obtained through hospital records. Hospitals’ data were collected through forms filled in loco and through open national databases. Generalized linear mixed models with logit link function were used for pooling mortality and to assess the association between hospital characteristics and mortality estimates. We built two models, one tested general hospital characteristics while the other tested ICU characteristics. All analyses were adjusted for the proportion of high-risk patients at admission. Thirty-one hospitals were included. The mean number of beds was 320.4 ± 186.6. These hospitals had eligible 6556 COVID-19 admissions during the study period. Estimated in-hospital mortality ranged from 9.0 to 48.0%. The first model included all 31 hospitals and showed that a private source of funding (β = − 0.37; 95% CI − 0.71 to − 0.04; p = 0.029) and location in areas with a high gross domestic product (GDP) per capita (β = − 0.40; 95% CI − 0.72 to − 0.08; p = 0.014) were independently associated with a lower mortality. The second model included 23 hospitals and showed that hospitals with an ICU work shift composed of more than 50% of intensivists (β = − 0.59; 95% CI − 0.98 to − 0.20; p = 0.003) had lower mortality while hospitals with a higher proportion of less experienced medical professionals had higher mortality (β = 0.40; 95% CI 0.11–0.68; p = 0.006). The impact of those association increased according to the proportion of high-risk patients at admission. In-hospital mortality varied significantly among Brazilian hospitals. Private-funded hospitals and those located in municipalities with a high GDP had a lower mortality. When analyzing ICU-specific characteristics, hospitals with more experienced ICU teams had a reduced mortality.
- Open Access
- 2 September 2022
- Published by Springer Nature in BMC Medicine
- Vol. 20 (1) , 1-13
Development and validation of the MMCD score to predict kidney replacement therapy in COVID-19 patients
Background: Acute kidney injury (AKI) is frequently associated with COVID-19, and the need for kidney replacement therapy (KRT) is considered an indicator of disease severity. This study aimed to develop a prognostic score for predicting the need for KRT in hospitalised COVID-19 patients, and to assess the incidence of AKI and KRT requirement. Methods: This study is part of a multicentre cohort, the Brazilian COVID-19 Registry. A total of 5212 adult COVID-19 patients were included between March/2020 and September/2020. Variable selection was performed using generalised additive models (GAM), and least absolute shrinkage and selection operator (LASSO) regression was used for score derivation. Accuracy was assessed using the area under the receiver operating characteristic curve (AUC-ROC). Results: The median age of the model-derivation cohort was 59 (IQR 47–70) years, 54.5% were men, 34.3% required ICU admission, 20.9% evolved with AKI, 9.3% required KRT, and 15.1% died during hospitalisation. The temporal validation cohort had similar age, sex, ICU admission, AKI, required KRT distribution and in-hospital mortality. The geographic validation cohort had similar age and sex; however, this cohort had higher rates of ICU admission, AKI, need for KRT and in-hospital mortality. Four predictors of the need for KRT were identified using GAM: need for mechanical ventilation, male sex, higher creatinine at hospital presentation and diabetes. The MMCD score had excellent discrimination in derivation (AUROC 0.929, 95% CI 0.918–0.939) and validation (temporal AUROC 0.927, 95% CI 0.911–0.941; geographic AUROC 0.819, 95% CI 0.792–0.845) cohorts and good overall performance (Brier score: 0.057, 0.056 and 0.122, respectively). The score is implemented in a freely available online risk calculator (https://www.mmcdscore.com/). Conclusions: The use of the MMCD score to predict the need for KRT may assist healthcare workers in identifying hospitalised COVID-19 patients who may require more intensive monitoring, and can be useful for resource allocation.
- 2 September 2022
- Published by Springer Nature in BMC Medicine
- Vol. 20 (1) , 1-13
Open AccessDevelopment and validation of the MMCD score to predict kidney replacement therapy in COVID-19 patients
Background: Acute kidney injury (AKI) is frequently associated with COVID-19, and the need for kidney replacement therapy (KRT) is considered an indicator of disease severity. This study aimed to develop a prognostic score for predicting the need for KRT in hospitalised COVID-19 patients, and to assess the incidence of AKI and KRT requirement. Methods: This study is part of a multicentre cohort, the Brazilian COVID-19 Registry. A total of 5212 adult COVID-19 patients were included between March/2020 and September/2020. Variable selection was performed using generalised additive models (GAM), and least absolute shrinkage and selection operator (LASSO) regression was used for score derivation. Accuracy was assessed using the area under the receiver operating characteristic curve (AUC-ROC). Results: The median age of the model-derivation cohort was 59 (IQR 47–70) years, 54.5% were men, 34.3% required ICU admission, 20.9% evolved with AKI, 9.3% required KRT, and 15.1% died during hospitalisation. The temporal validation cohort had similar age, sex, ICU admission, AKI, required KRT distribution and in-hospital mortality. The geographic validation cohort had similar age and sex; however, this cohort had higher rates of ICU admission, AKI, need for KRT and in-hospital mortality. Four predictors of the need for KRT were identified using GAM: need for mechanical ventilation, male sex, higher creatinine at hospital presentation and diabetes. The MMCD score had excellent discrimination in derivation (AUROC 0.929, 95% CI 0.918–0.939) and validation (temporal AUROC 0.927, 95% CI 0.911–0.941; geographic AUROC 0.819, 95% CI 0.792–0.845) cohorts and good overall performance (Brier score: 0.057, 0.056 and 0.122, respectively). The score is implemented in a freely available online risk calculator (https://www.mmcdscore.com/). Conclusions: The use of the MMCD score to predict the need for KRT may assist healthcare workers in identifying hospitalised COVID-19 patients who may require more intensive monitoring, and can be useful for resource allocation.
- Open Access
- 19 January 2022
- Published by Elsevier in International Journal of Infectious Diseases
- Vol. 116, 319-327
Hypothyroidism does not lead to worse prognosis in COVID-19: findings from the Brazilian COVID-19 registry
- 19 January 2022
- Published by Elsevier in International Journal of Infectious Diseases
- Vol. 116, 319-327
Open AccessHypothyroidism does not lead to worse prognosis in COVID-19: findings from the Brazilian COVID-19 registry